Atlanta, GA – Scibility Media – 10/29/2014.
This article discusses two companies: Pebblebrook Hotel Trust(NYSE:PEB) and Medidata Solutions Inc(NASDAQ:MDSO)
Pebblebrook Hotel Trust(NYSE:PEB) announced the pricing of a common offering of 3.2 million common shares yesterday. The announcement came five days after the real estate investment trust reported its third quarter 2014 financial results. The Maryland-based company, which invests in hotel properties throughout the United States, reported that it had invested $16.1 million in capital improvements throughout its portfolio, including $2.9 million in the Radisson Hotel Fisherman’s Wharf and $1.7 million in the Embassy Suites San Diego Bay – Downtown. The company expects an approximate net proceeds of $127.1 million from its public offering. Pebblebrook Hotel Trust has a market capitalization of over $2.7 billion and 67.75 million tradable shares.
Medidata Solutions Inc(NASDAQ:MDSO) is a New York-based healthcare information services company that provides cloud-based clinical development solutions for life sciences in the United States. The popularity of cloud-based solutions is spiking in the healthcare industry. As a result, Medidata Solutions is properly placed within its industry.
The New York-based company reported its third quarter financial results yesterday. The figures include a total revenue of $86 million, a 21% increase from the $70.9 million mark recorded for the same period during the previous fiscal year. However, Medidata Solutions only reported a GAAP net income of $0.2 million, or $0.00 per diluted share. This represents a $5.1 million decrease year-over-year.
EquiPress.com is a non-advertisement based network (currently in limited release) designed for investors to discover and communicate with publicly traded companies in real-time.
Sign-up for free now to experience the full benefits of EquiPress pre-launch.
Discover and communicate with companies you would otherwise never have seen based on your interests, company news, personalized news feeds, and one-on-one communications with no middle-men nor advertisements. Read our no advertisements pledge.
Can’t find your company on EquiPress? Send us an email to email@example.com and we will contact them for you.
Interested in a one month free trial? Get access to our private investor network, real-time news distribution, automatic disclaimers, corporate analytics, verified public profile, and industry-wide marketing of your corporate news.
Disclosure: EquiPress is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. EquiPress does not hold any equity or financial interest in any publicly traded company. EquiPress provides a uniform subscription based service to all publicly traded companies on a monthly basis at a rate of $495 to provide investor awareness. EquiPress receives only cash compensation from clients. Despite the relationship, EquiPress maintains a neutral stance (nonbiased) on any investment related opinions and exists solely for the purpose of allowing investors to communicate with the publicly traded companies in an effort to establish for themselves investment considerations. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor. Please visit www.equipress.com for complete risks and disclosures.